Skip to main content

Lipoprotein Particle Profiles, Standard Lipids, and Peripheral Artery Disease Incidence

Aaron W Aday, Patrick R Lawler, Nancy R Cook, Paul M Ridker, Samia Mora, Aruna D Pradhan

Circulation 2018

Study Details

Journal Circulation
Year 2018
1 min read

Leg artery disease isn’t just about “bad cholesterol”

What is PAD in plain words?

PAD means poor blood flow to the legs. Doctors explain it as: narrowed leg arteries cause pain when walking (claudication), and sometimes you need a procedure to open them.

What did this study find?

  • LDL cholesterol (the usual “bad cholesterol”) didn’t predict PAD well in women.
  • More LDL particles—especially small, dense ones—did predict higher PAD risk.
  • More triglyceride‑carrying particles (VLDL), especially medium and very large, also linked to higher risk.
  • Higher HDL (“good” cholesterol) and more HDL particles linked to lower risk.
  • A higher total cholesterol:HDL ratio strongly tracked PAD risk.

Where does this challenge common beliefs?

Focusing only on LDL cholesterol can miss PAD risk. Particle counts (LDL-P, HDL-P) and triglyceride‑rich particles (VLDL) tell a clearer story for leg arteries.

What to discuss with your doctor

  • What do my LDL, HDL, triglycerides, and TC:HDL ratio say about PAD risk?
  • Would advanced particle testing (LDL-P, HDL-P, VLDL-P) help assess my leg artery risk better than standard cholesterol alone?

Bottom line:

For PAD, it’s not just how much cholesterol—you need to know how many particles, how small they are, and how triglyceride‑rich they are. Relying on LDL-C alone may underestimate risk.